SCHEMBL7159396

SCHEMBL7159396

NC(C(=O)c1cccnc1)c1cccc2c1C=CS2(O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 1/20 0.40
F3 P13726 1/20 0.40
SARM1 Q6SZW1 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.40
SIRT6 Q8N6T7 1/20 0.40
SIRT1 Q96EB6 1/20 0.40
SIRT3 Q9NTG7 1/20 0.40
SIRT5 Q9NXA8 1/20 0.40
SIRT4 Q9Y6E7 1/20 0.40
ALDH1A1 P00352 3/20 0.38
APP P05067 1/20 0.38
GAA P10253 1/20 0.38
HCAR3 P49019 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
PLOD2 O00469 1/20 0.37
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7122853 0.72 HDAC1 (0.54) ALDH1A1GAAHDAC1KCNK3HTT
SCHEMBL7126807 0.70 NPC1 (0.52) GAACYP1A2CYP2C9TSHRCYP2C19
SCHEMBL27780057 0.69 F7 (0.62) F7F3SARM1SIRT2SIRT6
SCHEMBL6203223 0.68 ALDH1A1 (0.55) F7F3SARM1SIRT2SIRT6
SCHEMBL28659975 0.67 F7 (0.60) F7F3SARM1SIRT2SIRT6
SCHEMBL7126331 0.67 CYP2A6 (0.44) ALDH1A1CYP1A2CYP2C9CYP2C19KMO
SCHEMBL27259251 0.66 F7 (0.58) F7F3SARM1SIRT2SIRT6
SCHEMBL5288409 0.65 F7 (0.61) F7F3SARM1SIRT2SIRT6
SCHEMBL14523604 0.64 F7 (0.55) F7F3SARM1SIRT2SIRT6
SCHEMBL14074316 0.64 F7 (0.55) F7F3SARM1SIRT2SIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073706-A1 Fused thiophone derivatives and drugs containing the same as the active ingredient KONISHI MIKIO (JP) 2003-04-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073706-A1 Fused thiophone derivatives and drugs containing the same as the active ingredient TPMT, CD47, THPO F7 2707/4885F3 2421/4885SARM1 3472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.